✦ LIBER ✦

Cells defective for replication restart undergo replication fork reversal

✍ Scribed by Grompone, Gianfranco; Ehrlich, Dusko; Michel, Bénédicte

Book ID: 110032520
Publisher: Nature Publishing Group
Year: 2004
Tongue: English
Weight: 187 KB
Volume: 5
Category: Article
ISSN: 1469-221X
DOI: 10.1038/sj.embor.7400167

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

ATR activation and replication fork rest

ATR activation and replication fork restart are defective in FANCM-deficient cells

✍ Schwab, Rebekka A; Blackford, Andrew N; Niedzwiedz, Wojciech 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 695 KB

RuvAB is essential for replication forks

RuvAB is essential for replication forks reversal in certain replication mutants

✍ Baharoglu, Zeynep; Petranovic, Mirjana; Flores, Maria-Jose; Michel, Bénédicte 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 270 KB

Role for BLM in replication-fork restart

Role for BLM in replication-fork restart and suppression of origin firing after replicative stress

✍ Davies, Sally L; North, Phillip S; Hickson, Ian D 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 170 KB

The DNA repair helicase UvrD is essentia

The DNA repair helicase UvrD is essential for replication fork reversal in replication mutants

✍ Flores, Maria Jose; Bidnenko, Vladimir; Michel, Bénédicte 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 133 KB

ruvA and ruvB mutants specifically impai

ruvA and ruvB mutants specifically impaired for replication fork reversal

✍ Marie Le Masson; Zeynep Baharoglu; Bénédicte Michel 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 745 KB

Engineering cell lines for production of

Engineering cell lines for production of replication defective HSV-1 gene therapy vectors

✍ Kyle G. Grant; David M. Krisky; Mohammed M. Ataai; Joseph C. Glorioso III 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 467 KB

## Abstract Herpes simplex virus type 1 (HSV‐1) represents an attractive vehicle for a variety of gene therapy applications. To render this virus safe for clinical use, its cytotoxic genes must be removed without losing its ability to express transgenes efficiently. Our vectors are deleted for the